First Generic of a GLP-1 Injection Gets FDA Nod to Treat Type 2 Diabetes
Editor's note: this story was originally published on BioPharmInternational.com. FDA announced on Dec. 23, 2024 that it has approved Hikma Pharmaceuticals USA’s liraglutide injection, the first generic referencing Victoza (liraglutide injection) 18 mg…